Laboratory Corporation of America v. Patty Davis, etc. & Sheridan Radiology Services of Pinellas, Inc. v. Patty Davis, etc.

CourtSupreme Court of Florida
DecidedMay 26, 2022
DocketSC19-1923 & SC19-1936
StatusPublished

This text of Laboratory Corporation of America v. Patty Davis, etc. & Sheridan Radiology Services of Pinellas, Inc. v. Patty Davis, etc. (Laboratory Corporation of America v. Patty Davis, etc. & Sheridan Radiology Services of Pinellas, Inc. v. Patty Davis, etc.) is published on Counsel Stack Legal Research, covering Supreme Court of Florida primary law. Counsel Stack provides free access to over 12 million legal documents including statutes, case law, regulations, and constitutions.

Bluebook
Laboratory Corporation of America v. Patty Davis, etc. & Sheridan Radiology Services of Pinellas, Inc. v. Patty Davis, etc., (Fla. 2022).

Opinion

Supreme Court of Florida ____________

No. SC19-1923 ____________

LABORATORY CORPORATION OF AMERICA, et al., Petitioners,

vs.

PATTY DAVIS, etc., et al., Respondents.

____________

No. SC19-1936 ____________

SHERIDAN RADIOLOGY SERVICES OF PINELLAS, INC., et al., Petitioners,

May 26, 2022

PER CURIAM.

In this case we consider the interaction between the statutory

remedy for prohibited consumer debt collection practices provided by the Florida Consumer Collection Practices Act (FCCPA) 1 and the

provision of the Workers’ Compensation Law (WCL)2 vesting the

Department of Financial Services (DFS) with exclusive jurisdiction

to decide matters concerning workers’ compensation

reimbursement. Before the Court for review is the decision of the

Second District Court of Appeal in Davis v. Sheridan Healthcare,

Inc., 281 So. 3d 1259 (Fla. 2d DCA 2019), in which the court held

the WCL exclusive jurisdiction provision to be inapplicable as a bar

to suit by an injured worker against a health care provider for

prohibited debt collection practices. Id. at 1261. The Second

District certified the following question to be of great public

importance:

DOES SECTION 440.13(11)(c) OF THE WORKERS’ COMPENSATION LAW PRECLUDE CIRCUIT COURT JURISDICTION OVER CLAIMS UNDER SECTION 559.77(1) OF THE FLORIDA CONSUMER COLLECTION PRACTICES ACT?

Id. at 1267. We have jurisdiction. See art. V, § 3(b)(4), Fla. Const.

1. §§ 559.55-559.785, Fla. Stat. (2014).

2. Ch. 440, Fla. Stat. (2014).

-2- We answer the certified question in the negative and approve the

result reached by the Second District.

I

Patty Davis was injured during the course of her employment.

Subsequently, Davis utilized workers’ compensation benefits to

receive medical care for her work-related injuries. Davis received

medical care from two providers: Sheridan Radiology Services of

Pinellas, Inc., a subsidiary of Sheridan Healthcare, Inc. (Sheridan);

and Laboratory Corporation of America and Laboratory Corporation

of America Holdings (Labcorp). Thereafter, Sheridan and Labcorp

repeatedly billed Davis directly for the medical care that she

received.

Davis then filed two separate actions against Sheridan and

Labcorp under section 559.77(1), Florida Statutes (2014), of the

FCCPA. Davis argued that as an injured employee under the

WCL—chapter 440, Florida Statutes (2014)—she was not to be

billed for seeking medical care for her work-related injuries.

Instead, according to Davis’s claim, her employer’s workers’

compensation carrier, Commercial Risk Management, Inc. (CRM),

was responsible for reimbursing Sheridan and Labcorp. In turn,

-3- Davis maintained that Sheridan and Labcorp’s attempts to collect

the debt from her constituted an attempt to collect an illegitimate

debt, violating section 559.72, Florida Statutes (2014), of the

FCCPA.

In response, Sheridan and Labcorp asserted that the trial

courts lacked subject matter jurisdiction for the alleged FCCPA

violations. Under Sheridan and Labcorp’s reasoning, section

440.13(11)(c) of the WCL unequivocally states that DFS “has

exclusive jurisdiction to decide any matters concerning

reimbursement.” Consequently, Sheridan and Labcorp claimed,

because their billing Davis was merely a “matter[] concerning

reimbursement,” exclusive jurisdiction over the matter was vested

in DFS.

The trial courts agreed with Sheridan and Labcorp and

dismissed Davis’s FCCPA claims. Davis appealed. In its

consolidated opinion, the Second District held that “the WCL does

not preclude Davis’s claims filed against her workers’ compensation

medical providers under section 559.77(1) of the FCCPA,” reversed

both trial court dismissals, and certified to this Court the question

-4- of great public importance set forth above. Davis, 281 So. 3d at

1261, 1267.

II

Section 559.72 of the FCCPA prohibits various debt collection

practices. Subsection (9) provides that “no person shall . . . [c]laim,

attempt, or threaten to enforce a debt when such person knows

that the debt is not legitimate, or assert the existence of some other

legal right when such person knows that the right does not exist.”

Section 559.77 contains provisions authorizing and governing civil

remedies for violations of the FCCPA. Subsection (1) provides that

“[a] debtor may bring a civil action against a person violating the

provisions of s. 559.72.” Subsection (2) provides for the award of

“actual damages and for additional statutory damages . . . not

exceeding $1,000.” Punitive damages and other equitable relief are

also authorized.

Section 440.13 of the WCL establishes the framework for the

provision of medical services to injured workers and for the

reimbursement of medical providers by carriers and employers for

those services. Subsection (3)(g) provides that “[t]he employee is not

liable for payment for medical treatment or services provided

-5- pursuant to this section except as otherwise provided in this

section.” In addition, subsection (13)(a) provides that “provider[s]

may not collect or receive a fee from an injured employee within this

state” unless otherwise provided and that “providers have recourse

against the employer or carrier for payment for services rendered in

accordance with [the WCL].” 3

Subsection (11)(a) of section 440.13 grants DFS the power to

“investigate health care providers to determine whether providers

are complying with [the WCL] and with rules adopted by [DFS],”

including “whether the providers are engaging in overutilization,

3. Under subsection (5)(a) of section 440.13, an employee “requesting and selecting [an] independent medical examination shall be responsible for all expenses associated with said examination, including, but not limited to, medically necessary diagnostic testing performed and physician or medical care provider fees for the evaluation,” but “[i]f the employee prevails in a medical dispute as determined in an order by a judge of compensation claims or if benefits are paid or treatment provided after the employee has obtained an independent medical examination based upon the examiner’s findings, the costs of such examination shall be paid by the employer or carrier.” Subsection (5)(d) provides that an employee who without justification and proper notice fails to appear for an independent medical examination properly scheduled by a carrier or employer “shall reimburse the employer or carrier 50 percent of the physician’s cancellation or no-show fee.”

-6- [and] whether providers are engaging in improper billing practices.” 4

“If [DFS] finds that a health care provider has improperly billed,

overutilized, or failed to comply with [DFS] rules or the

requirements of [the WCL]” DFS “may determine that the health

care provider may not receive payment from the carrier or may

impose penalties as set forth [elsewhere in the WCL].” If a provider

has received improper payments “from a carrier,” the provider

“must return those payments to the carrier.” DFS is authorized to

impose “a penalty not to exceed $500” for overpayments that are

not timely refunded.

Subsection (11)(c)—which is the focus of the issue presented

by this case—provides that DFS “has exclusive jurisdiction to decide

any matters concerning reimbursement, to resolve any overutilization

Free access — add to your briefcase to read the full text and ask questions with AI

Related

Deal v. United States
508 U.S. 129 (Supreme Court, 1993)

Cite This Page — Counsel Stack

Bluebook (online)
Laboratory Corporation of America v. Patty Davis, etc. & Sheridan Radiology Services of Pinellas, Inc. v. Patty Davis, etc., Counsel Stack Legal Research, https://law.counselstack.com/opinion/laboratory-corporation-of-america-v-patty-davis-etc-sheridan-radiology-fla-2022.